share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股sec公告 ·  06:06
Moomoo AI 已提取核心訊息
The United States Securities and Exchange Commission (SEC) has declared that the Form S-3 filed by 60 Degrees Pharmaceuticals, Inc. is now effective as of July 18, 2024, at 9:00 A.M. The Form S-3 is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that 60 Degrees Pharmaceuticals has met all the necessary regulatory requirements to potentially offer securities to investors. The company's CIK number is 0001946563, and the file number for this particular form is 333-280796.
The United States Securities and Exchange Commission (SEC) has declared that the Form S-3 filed by 60 Degrees Pharmaceuticals, Inc. is now effective as of July 18, 2024, at 9:00 A.M. The Form S-3 is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that 60 Degrees Pharmaceuticals has met all the necessary regulatory requirements to potentially offer securities to investors. The company's CIK number is 0001946563, and the file number for this particular form is 333-280796.
美國證券交易委員會(SEC)宣佈,60 Degrees Pharmaceuticals, Inc.提交的S-3表格現已於2024年7月18日上午9:00生效。S-3表格是一種註冊聲明,允許公司向公衆發行各種證券。這個表單的生效意味着60 Degrees Pharmaceuticals已經滿足了所有必要的監管要求,有可能向投資者發行證券。該公司的CIk號碼爲0001946563,這個特定表格的文件號爲333-280796。
美國證券交易委員會(SEC)宣佈,60 Degrees Pharmaceuticals, Inc.提交的S-3表格現已於2024年7月18日上午9:00生效。S-3表格是一種註冊聲明,允許公司向公衆發行各種證券。這個表單的生效意味着60 Degrees Pharmaceuticals已經滿足了所有必要的監管要求,有可能向投資者發行證券。該公司的CIk號碼爲0001946563,這個特定表格的文件號爲333-280796。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息